Literature DB >> 19471024

CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Roy L Silverstein1, Maria Febbraio.   

Abstract

CD36 is a membrane glycoprotein present on platelets, mononuclear phagocytes, adipocytes, hepatocytes, myocytes, and some epithelia. On microvascular endothelial cells, CD36 is a receptor for thrombospondin-1 and related proteins and functions as a negative regulator of angiogenesis. On phagocytes, through its functions as a scavenger receptor recognizing specific oxidized phospholipids and lipoproteins, CD36 participates in internalization of apoptotic cells, certain bacterial and fungal pathogens, and modified low-density lipoproteins, thus contributing to inflammatory responses and atherothrombotic diseases. CD36 also binds long-chain fatty acids and facilitates their transport into cells, thus participating in muscle lipid utilization, adipose energy storage, and gut fat absorption and possibly contributing to the pathogenesis of metabolic disorders, such as diabetes and obesity. On sensory cells, CD36 is involved in insect pheromone signaling and rodent fatty food preference. The signaling pathways downstream of CD36 involve ligand-dependent recruitment and activation of nonreceptor tyrosine kinases, specific mitogen-activated protein kinases, and the Vav family of guanine nucleotide exchange factors; modulation of focal adhesion constituents; and generation of intracellular reactive oxygen species. CD36 in many cells is localized in specialized cholesterol-rich membrane microdomains and may also interact with other membrane receptors, such as tetraspanins and integrins. Identification of the precise CD36 signaling pathways in specific cells elicited in response to specific ligands may yield novel targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471024      PMCID: PMC2811062          DOI: 10.1126/scisignal.272re3

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  123 in total

1.  Type I CD36 deficiency in humans is not associated with insulin resistance syndrome.

Authors:  H Yanai; H Chiba; M Morimoto; G A Jamieson; K Matsuno
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.

Authors:  M Janabi; S Yamashita; K Hirano; N Sakai; H Hiraoka; K Matsumoto; Z Zhang; S Nozaki; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

3.  Reversing atherosclerosis?

Authors:  Linda K Curtiss
Journal:  N Engl J Med       Date:  2009-03-12       Impact factor: 91.245

4.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

5.  Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.

Authors:  E A Podrez; M Febbraio; N Sheibani; D Schmitt; R L Silverstein; D P Hajjar; P A Cohen; W A Frazier; H F Hoff; S L Hazen
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; S E Crawford; M Febbraio; R L Silverstein; N Bouck
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

7.  The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.

Authors:  Diala Harb; Kim Bujold; Maria Febbraio; Martin G Sirois; Huy Ong; Sylvie Marleau
Journal:  Cardiovasc Res       Date:  2009-03-05       Impact factor: 10.787

8.  The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function.

Authors:  Sarah J Hoosdally; Edward J Andress; Carol Wooding; Catherine A Martin; Kenneth J Linton
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

9.  FAT/CD36 expression is not ablated in spontaneously hypertensive rats.

Authors:  Arend Bonen; Xiao-Xia Han; Narendra N Tandon; Jan F C Glatz; James Lally; Laelie A Snook; Joost J F P Luiken
Journal:  J Lipid Res       Date:  2008-12-09       Impact factor: 5.922

10.  Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.

Authors:  Terry K Means; Eleftherios Mylonakis; Emmanouil Tampakakis; Richard A Colvin; Edward Seung; Lindsay Puckett; Melissa F Tai; Cameron R Stewart; Read Pukkila-Worley; Suzanne E Hickman; Kathryn J Moore; Stephen B Calderwood; Nir Hacohen; Andrew D Luster; Joseph El Khoury
Journal:  J Exp Med       Date:  2009-02-23       Impact factor: 14.307

View more
  387 in total

1.  TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia.

Authors:  Sudipta Biswas; Alejandro Zimman; Detao Gao; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2017-08-03       Impact factor: 17.367

2.  Common variants in the CD36 gene are associated with oral fat perception, fat preferences, and obesity in African Americans.

Authors:  Kathleen L Keller; Lisa C H Liang; Johannah Sakimura; Daniel May; Christopher van Belle; Cameron Breen; Elissa Driggin; Beverly J Tepper; Patricia C Lanzano; Liyong Deng; Wendy K Chung
Journal:  Obesity (Silver Spring)       Date:  2012-01-12       Impact factor: 5.002

Review 3.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

4.  Scavenger receptor class-A has a central role in cerebral ischemia-reperfusion injury.

Authors:  Chen Lu; Fang Hua; Li Liu; Tuanzhu Ha; John Kalbfleisch; John Schweitzer; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

5.  Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides.

Authors:  Laibaik Park; Ken Uekawa; Lidia Garcia-Bonilla; Kenzo Koizumi; Michelle Murphy; Rose Pistik; Linda Younkin; Steven Younkin; Ping Zhou; George Carlson; Josef Anrather; Costantino Iadecola
Journal:  Circ Res       Date:  2017-05-17       Impact factor: 17.367

Review 6.  Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.

Authors:  Julie A Peterson; Janice G McFarland; Brian R Curtis; Richard H Aster
Journal:  Br J Haematol       Date:  2013-02-06       Impact factor: 6.998

7.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.

Authors:  Laibaik Park; Joan Zhou; Ping Zhou; Rose Pistick; Sleiman El Jamal; Linda Younkin; Joseph Pierce; Andrea Arreguin; Josef Anrather; Steven G Younkin; George A Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis.

Authors:  Robin D Clugston; Jason J Yuen; Yunying Hu; Nada A Abumrad; Paul D Berk; Ira J Goldberg; William S Blaner; Li-Shin Huang
Journal:  J Lipid Res       Date:  2013-11-26       Impact factor: 5.922

Review 9.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

10.  Cancer: Destiny from density.

Authors:  Victoria L Seewaldt
Journal:  Nature       Date:  2012-10-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.